Riskpilot← Back to searchSign inGet full accessMedicapital Oy
OYDissolvedY-tunnus 2013906-9Munkkiniemenranta 25Other human health activities n.e.c. · NACE 8699Est. 20061 employees
Revenue 2024
EUR 415K
-2% vs 2023
EBITDA margin
59.1%
+3% vs 2023
Equity ratio
65.3%
Financial strength
Net profit 2024
EUR 199K
+17% vs 2023
| Revenue | EUR 415K | -2% |
| EBITDA | EUR 246K | +3% |
| Net profit | EUR 199K | +17% |
| Total assets | EUR 810K | +46% |
| Equity | EUR 529K | +4% |
| Employees | 1 | — |
Legal name
Medicapital Oy
Y-tunnus number
2013906-9
Legal form
Osakeyhtiö
NACE code
8699 · Other human health activities n.e.c.
Founded
19. tammikuuta 2006
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Yhtiön toimialana on lääketieteellisten palveluiden, tutkimusten ja konsultaation tarjoaminen ja näihin liittyvät hallinnolliset palvelut. Yhtiö voi ostaa, myydä, vuokrata ja omistaa kiinteää omaisuutta sekä arvopapereita.
Address
Munkkiniemenranta 25
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 421 | 364 | 401 | 423 | 415 |
| Staff expenses | −13 | −14 | −43 | −40 | −40 |
| EBITDA | 287 | 239 | 239 | 238 | 246 |
| Depreciation & amort. | −14 | −10 | −18 | −13 | −10 |
| EBIT | 273 | 229 | 221 | 225 | 235 |
| Net financials | 23 | 20 | −0 | −15 | 9 |
| Profit before tax | 296 | 249 | 221 | 216 | 247 |
| Tax | 64 | 58 | 43 | 46 | 48 |
| Net profit | 232 | 191 | 178 | 170 | 199 |
| Item | 2019 | 2020 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 580 | 559 | 572 | 556 | 810 |
| Equity | 417 | 439 | 547 | 511 | 529 |
| Long-term debt | 150 | 100 | 22 | 0 | 220 |
| Short-term debt | 13 | 19 | 3 | 38 | 56 |
| Total debt | 163 | 119 | 25 | 38 | 276 |
EBITDA margin
59.1%
This company
15.8%
Market median
+274% vs market
20192024
Equity ratio
65.3%
This company
38.2%
Market median
+71% vs market
20192024
Return on equity
37.6%
This company
18.4%
Market median
+104% vs market
20192024
Net profit margin
47.9%
This company
8.1%
Market median
+491% vs market
20192024
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
20192024
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
20192024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TM Deputy Member | Deputy Member | 2008 |
CE Audit | Audit | 2008 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2008 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medicapital Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Terhi Marjaana Ylänne-Pippingsköld | Deputy Member | 0 companies |
| Carl Erik Johnsson | Audit | 0 companies |
| Peter Markus Pippingsköld | Board of Directors | 0 companies |